ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

4.85
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.85 4.70 5.00 4.85 4.85 4.85 12,857 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -11.55 25.87M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.85p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £25.87 million. Eden Research has a price to earnings ratio (PE ratio) of -11.55.

Eden Research Share Discussion Threads

Showing 3826 to 3846 of 18075 messages
Chat Pages: Latest  159  158  157  156  155  154  153  152  151  150  149  148  Older
DateSubjectAuthorDiscuss
05/3/2018
15:31
Supersonica Interesting read.Wonder why UK supermarkets & UK gov isn't taking notice of this?Are they all turning a blind eye to this
northwick
05/3/2018
15:20
(Beyond Pesticides, March 5, 2018) Even if you don’t live in California, chances are that you eat food that is grown there. Unless all that food is organic, some of it was probably sprayed with chlorpyrifos, exposing not only you, but also the farmworkers responsible for its cultivation and harvest. Farmworker families –especially children—who usually live close to the treated fields, suffer higher impacts than those living further away.
supersonico
05/3/2018
15:04
Neonicotinoids: ANSES publishes its second progress report on the alternatives and conclusions of its expert work on the impact on human health of these active substances

In application of the law "For the reconquest of biodiversity, nature and landscapes", ANSES undertook work to evaluate chemical and non-chemical alternatives to the use of plant protection preparations based on neonicotinoids, including the final report will be published in the second quarter of 2018. In the second progress report published today, alternatives to the use of grapes, industrial and fodder beet, straw cereals, maize and lettuce have been identified and risk indicators have been used. been applied. These elements will be included in a final report that will cover all the plant protection uses of neonicotinoids, as well as an update of the alternatives identified for each use. As regards the impact of neonicotinoids on human health, the expertise carried out at the request of the ministers responsible for health and the environment does not show any harmful effect, for uses that respect the conditions of use set by marketing authorizations. However, in the case of thiacloprid, given the hazard characteristics of the substance and the significant increase in its use, the Agency recommends that its uses be minimized.

The law "For the recovery of biodiversity, nature and landscapes" of 8 August 2016 (Article 125) provides for the prohibition of the use of plant protection products containing active substances of the neonicotinoid family as well as treated seeds. with these products as of September 1, 2018. The law also provides that exemptions may be granted until July 1, 2020 on the basis of a comparison established by ANSES on the benefits and risks associated with the use of these products. with those of substitute products or alternative methods.
In this context, ANSES was asked by the Ministry of Agriculture to carry out an assessment weighing the risks and benefits of plant protection preparations based on neonicotinoids and their chemical and non-chemical alternatives. The ministries in charge of health, environment and biodiversity, have also commissioned ANSES to carry out in-depth expertise on the impacts on human health of all nationally authorized neonicotinoid substances, regardless of their uses: phytopharmaceutical, biocidal or as a veterinary medicinal product.

Impact of neonicotinoids on human health: no adverse effect on human health in compliance with the conditions of use set by the marketing authorizations but particular vigilance on thiacloprid
To carry out its work, ANSES examined the available data on the human health hazards presented by the six active substances of the family of neonicotinoids authorized under the regulations relating to plant protection products and / or biocides and and / or veterinary drugs (acetamiprid, clothianidin, imidacloprid, thiacloprid, thiamethoxam and dinotefuran). These works do not show any harmful effect on human health, in compliance with the conditions of use laid down in the marketing authorizations. The Agency therefore recalls the importance of respecting the conditions of use laid down in product marketing authorizations to prevent possible impacts on human health.

However, with regard to the active substance thiacloprid, and taking into account its hazard characteristics, the significant increase in its use during the period 2010-2015, and the uncertainties related to cumulative exposures with other products phytopharmaceuticals or biocides with similar hazard characteristics, ANSES recommends minimizing the use of products based on this substance as early as 2018.

Evaluation of alternatives: development of an innovative method of comparing substances with regard to each type of risk
The ban on the use of plant protection products or treated seeds based on one or more active substances of the neonicotinoid family is provided for by the law "For the recovery of biodiversity, nature and landscapes" from the 1st September 2018. Exemptions may, however, be granted until 1 July 2020 by joint order of the ministers responsible for agriculture, environment and health, on the basis of a balance sheet drawn up by ANSES, which compares the benefits and risks related to the use of plant protection products containing active substances of the family of neonicotinoids authorized in France with those related to the use of substitute products or alternative methods available.

To answer this question, the Agency has developed a methodology for identifying and rating alternatives to the use of neonicotinoids, published in its first report in March 2017. The analysis grid used allows for a consistent and systematic comparison of alternative control methods - chemical and non-chemical, for each use of neonicotinoids, based on four criteria: the effectiveness, the operationality, the durability and the practicality of each method considered.
In its second progress report published today, this methodology has been applied to uses on vineyards, industrial and fodder beet, straw cereals, corn and lettuce. The elements it contains will be included in a final report, which will include all plant protection uses, as well as an update of the identification of alternatives with a marketing authorization.
The approach adopted made it possible to identify and evaluate control methods (chemical or agronomic) that could represent an alternative to the use of neonicotinoids as early as 2018. The analysis also presents risk indicators that allow for a comparison of substances. between them, be they risks to humans, to the environment, as well as to soil organisms, aquatic organisms, birds, mammals or pollinators.

It should be recalled that as far as pest control is concerned, no single method alone ensures sufficient efficacy: a combination of methods should therefore be considered as part of an integrated pest management approach.
The final report on the evaluation of chemical and non-chemical alternatives to the use of neonicotinoid-based plant protection preparations will be published in the second quarter of 2018. It will include an update of authorized chemical alternatives and the application of comparative methodologies. all authorized uses for neonicotinoid products.

supersonico
05/3/2018
11:41
Conservation Groups, House Reps Call for EPA to Respect Science, Take Action on Pollinator-Killing Pesticides
supersonico
03/3/2018
15:34
...............................

Pipeline
Mevalone (3AEY): Botrytis (Grapes & Soft Fruits, Powdery Mildew, GH Vegetable)
Cedroz(r) (B2Y): Nematodes, protected crops, outdoor vegetables *Cedroz is a TM of Eastman Chemical
2EY: Powdery Mildew, outdoor vegetables
G3Y: Molluscicide
Insecticide: White fly, spider mites

supersonico
03/3/2018
13:03
Parking

DR Mario Tenuta / cyst Nematode
...............................................................

Root cystnematodes - (Pratylenchus penetrans) - The root cyst nematode can live on a large number of plants. For strawberries it is the most dangerous nematode species. Nematodes spend their entire life cycle in the roots of the plants. One generation will last about six or seven weeks. Attacked plants show interrupted growth, produce fewer runners and will die. As a result of this, so-called eelworm patches form in the crop. Especially on light soil this eelworm may cause damage. The development of the roots of attacked plants is far poorer. The ends of the roots are thickened and the root hair is lacking. An attacked plant is growing as it were on the soil and can be easily pulled out of the soil. Through the damaged roots fungi - for example black root rot - can penetrate into the plants.


...................

















REFERENCES to Metam Sodium and Potasium

Table 2. Generalized summary of maximum use rate and relative effectiveness of various soil fumigant alternatives to methyl bromide for nematode, soilborne disease, and weed control in Florida.

Effectiveness judged 'Good to Poor' for Nematode /disease/ weed treatments.

supersonico
03/3/2018
12:08
Super

Good to have some Blue Sky thoughts now and again. "Mr Blue Sky's up there waitin' and today is the day we've waited for." (ELO).
I get the feeling that Eden and its partners have at last engaged first gear and maybe are about to slowly let the handbrake off.
Perhaps one day we will look back and say, "Are yes.....2018 was a vintage year."

littlealbatross2
02/3/2018
19:14
littlealbatross2

Just having some Blue sky thoughts... 'beyond our current market'.

supersonico
02/3/2018
17:33
Thinking aloud...

This report quoted in Itaconix ltd 2018 presentation.(Rob Cridland's CFO Company)

It has some interesting numbers in it's summary and talks about Sustainability; the Mega Trend of Our Generation.

Microencapsulation Market Size To Reach USD 17.94 Billion By 2025





I ask myself could the 'excellent Potential' for Eden's Sustainable encapsulation Technology beyond it's current market be associated with the market Itaconix occupy?

Rob joined Eden May2015

Investing,, post 3433

'My understanding when asking this question at the 2017 AGM is that the timeline for the Encapsulation technology to be sold as a stand-alone and therefore separate of Eden Active ingredient compositions is that this was about a 5 year process to commercialisation. If that is still accurate, I would estimate from Sean Smith's response that we are 60% of the way through this'

supersonico
02/3/2018
16:27
Interesting read Super. Might Eden's technology find an application one wonders.
littlealbatross2
02/3/2018
15:32
FAO Mr S Smith & Mr R Cridland
supersonico
02/3/2018
11:34
You are right that at least eden has never over stated anything or mislead investors, or withheld bad news.
paulpaolo
02/3/2018
09:29
Regulatory Affairs project mgr Crop Protection BE

Date: Feb 27, 2018
Location: Ghent North, BE

supersonico
02/3/2018
08:16
Silent Spring Groundhog day 2018 News
supersonico
01/3/2018
13:13
I'd be interested in Sean Smith's opinion on what the development of mildew resistant varieties pose to Eden market.



INRA presents at the Salon de l'Agriculture the first four vine stocks from its research, carrying genes resistant to powdery mildew and mildew, which will reduce further 70% the use of pesticides on the vine.

We plan to release twenty new varieties of grape varieties in 2019, "he added.
The grape varieties are not derived from genetic mutations but from traditional breeding and crossbreeding, he said, highlighting the work of "long breath and modesty" necessary to "identify wildly resistant genes on wild vines", cross them with varieties already used in viticulture, and then test them in life size, "going to the harvest and to the wine".
INRA has been working on the subject for about twenty years, and for the first time this year has added four new varieties to the catalog, he said.
"There is real hope for the vine now," says Mauguin. "We can reduce by up to 80% the volume of pesticides used to fight against powdery mildew and downy mildew, the two main pests of the vineyard."
Behind a counter, the researcher Frédérique Pelsy, president of the INRA center in Colmar, has turned the space of an afternoon cellar to test three 2017 wines, from the same plot in the Vaucluse.
The first, a 13.5-degree "test" wine, comes from a traditional Grenache grape variety and has received nine treatments of plant protection products during its growth.

Access 100% local items from € 1 / month
The second, a light wine with 11.7 degrees alcohol, comes from the new grape variety Artaban, and the third, Vidoc, more robust, has 12.3 degrees of alcohol. The two new kids were only treated twice each.
Serge Barbary, Senator LR from Indre-et-Loire, who had a special presentation on a senatorial mission, raised his glass "to French viticulture and research". "It's very comforting for professionals," he told AFP.

////////.....................................................................................................................................................

supersonico
28/2/2018
20:58
PaulPaolo,

Eden could never be accused of whipping up the share price. It's is about education and widening their reach and appeal.

Eden's shares are illiquid and static

investingisatrickygame
28/2/2018
18:45
Further reaction to Cash Impact Documentary..






.................................

supersonico
28/2/2018
16:59
I don't mind if they only update us at prelims. I am not a speculator and wish to buy more eden end april when i have some dough. They don't need to keep whipping up the share price with many pathetic little RNSs like some other AIM shares do, None of their RNSs have ever been bad so I'm fine to wait. With many strings to their bow they are not dependent on any one outcome unlike some dodgy mining or oil and gas firms.
paulpaolo
28/2/2018
13:29
Neonicotinoids: risks to bees confirmed



Most uses of neonicotinoid pesticides represent a risk to wild bees and honeybees, according to assessments published today by EFSA. The Authority has updated its risk assessments of three neonicotinoids – clothianidin, imidacloprid and thiamethoxam – that are currently subject to restrictions in the EU because of the threat they pose to bees.
These new conclusions update those published in 2013, after which the European Commission imposed controls on use of the substances.
For the new assessments, which this time cover wild bees – bumblebees and solitary bees – as well as honeybees, EFSA’s Pesticides Unit carried out an extensive data collection exercise, including a systematic literature review, to gather all the scientific evidence published since the previous evaluations.
The team also applied the guidance document developed by EFSA specifically for the risk assessment of pesticides and bees.
Jose Tarazona, Head of EFSA’s Pesticides Unit, said: “The availability of such a substantial amount of data as well as the guidance has enabled us to produce very detailed conclusions.

“There is variability in the conclusions, due to factors such as the bee species, the intended use of the pesticide and the route of exposure. Some low risks have been identified, but overall the risk to the three types of bees we have assessed is confirmed.”
EFSA finalised its conclusions following two separate consultations with pesticide experts in the EU Member States. The experts have supported the conclusions.
As with the previous assessments, exposure of bees to the substances was assessed via three routes: residues in bee pollen and nectar; dust drift during the sowing/application of the treated seeds; and water consumption.

Next steps
EFSA’s conclusions will be shared with risk managers from the European Commission and Member States, who will consider potential amendments to the current restrictions on the use of these pesticides.
Peer review of the pesticide risk assessment for bees for the active substance clothianidin considering the uses as seed treatments and granules
Peer review of the pesticide risk assessment for bees for the active substance imidacloprid considering the uses as seed treatments and granules
Peer review of the pesticide risk assessment for bees for the active substance thiamethoxam considering the uses as seed treatments and granules
Evaluation of the data on clothianidin, imidacloprid and thiamethoxam for the updated risk assessment to bees for seed treatments and granules in the EU
Q&A: Conclusions on neonicotinoids 2018 (PDF)
....................................................................................................................

supersonico
28/2/2018
11:36
Supersonico,

From post 3431

"Looking back at the 2017 presentation I would be keen to know what progress Eden are making with regard to the following statement;

'There is excellent potential for the application of Eden’sSustaine™ encapsulation technology and natural chemistry beyond its current market'.



This suggests to me new partners and would like to hear more from Eden of what this 'excellent potential' may be. If I was making that statement I would want to have something achievable and tangible in mind and probably 90% in the bag."


My understanding when asking this question at the 2017 AGM is that the timeline for the Encapsulation technology to be sold as a stand-alone and therefore separate of Eden Active ingredient compositions is that this was about a 5 year process to commercialisation. If that is still accurate, I would estimate from Sean Smith's response that we are 60% of the way through this. You may want to email him to get a more up-to-date and comprehensive understanding of this and obviously your question.

However, taking their natural application and technology combined and beyond current named markets may be totally different, so it is worth asking this question too. I assume it would mean

1) More trials by potential user
2) Regulatory approvals
3) User to product switch, re-postion etc
3) Market execution
4) Market adoption

Based on current commercial arrangements and allowing for our partners, with Eden, to execute 1-4 then I would assume that to be a few years away, at least.

One point, Eden has said for a long time that their products are 'GRAS' Generally Regarded As Safe and I understood that to mean in the USA a quicker route to approval and market uptake. We don't hear anything about this and the shortening of regulatory approval in the US or elsewhere in the world where this may apply.

Launching new products into new territories under this status, should as I understand it, speed everything up materially. Maybe you could ask Sean Smith this generic question you, should you email him.

investingisatrickygame
28/2/2018
10:54
Investing,

Yes based on what I have read I'm optimistic that our new Chairman along with the current slowly expanding Team (Peter Watson/ Lames Clovis / James Kennedy / Michel Villeneuve) as well as the influence of Sipcam, LivingBridge and Powerscourt will be positive. I am glass half full on Eden as you know.

Looking back at the 2017 presentation I would be keen to know what progress Eden are making with regard to the following statement;

'There is excellent potential for the application of Eden’sSustaine™ encapsulation technology and natural chemistry beyond its current market'.



This suggests to me new partner in new market, one not yet discussed. I would like to hear more from Eden of what this 'excellent potential' may be. If I was making that statement I would want to have something achievable and tangible in mind and probably 90% in the bag.

supersonico
Chat Pages: Latest  159  158  157  156  155  154  153  152  151  150  149  148  Older

Your Recent History

Delayed Upgrade Clock